Navigation Links
GeoVax Labs' CEO Update Letter to Shareholders
Date:1/9/2012

299 participant trial in North and South America. GeoVax is also enrolling volunteers in a Phase 1/2 therapeutic trial for individuals already infected with HIV. For more information, please visit www.geovax.com.

Forward-Looking Statements

Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax can develop and manufacture its vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. More information about these factors is contained in GeoVax's filings with the Securities and Exchange Commission including those set forth at "Risk Factors" in GeoVax's Form 10-K.

Contact

The Investor Relations Group:
Erika Moran, Investor Relations
Janet Vasquez, Public Relations
(212) 825-3210


'/>"/>
SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
2. GeoVax Phase 2a Clinical Trial Completes Enrollment
3. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
4. GeoVax Labs, Inc. Announces Second Quarter Financial Results
5. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
6. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
7. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
8. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
9. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
10. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
11. GeoVax Labs Engages The Investor Relations Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014   What:   ... present data from a Phase I clinical trial of ... stop Parkinson,s disease progression. The Michael J. Fox Foundation ... will discuss the impact of the results for patients ... July 31, 2014         ...
(Date:7/29/2014)... 29, 2014  Drug development for hepatitis C ... rates and the intense need for curative therapy ... is underway as the market moves away from ... easily-tolerated, interferon-free oral therapies. Logo ... mega blockbuster Sovaldi is the first of these ...
(Date:7/29/2014)... RESEARCH TRIANGLE PARK, N.C. , July 29, ... focused on cloud-based drug design and development, announced ... I grant from the National Science Foundation Small ... is valued at $150,000. Cloud ... accelerates the development process by implementing new, innovative ...
Breaking Medicine Technology:Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000 2
... (NASDAQ: SVA ), a leading provider of biopharmaceutical ... Lee as a director to the Board of the Company ... who resigned from the Board due to personal reasons. ... a leading growth capital fund focused on China and India. ...
... The Neuroblastoma and Medulloblastoma Translational Research Consortium ... genomic-based clinical trial to treat and study pediatric ... The 11-member NMTRC, housed at Van ... of pediatric cancer clinical trial sites that includes ...
Cached Medicine Technology:Sinovac Appoints Kenneth Lee to Board of Directors 2Consortium Opens Landmark Personalized Medicine Children's Cancer Trial 2
(Date:7/29/2014)... NJ (PRWEB) July 29, 2014 Helping ... is an immensely complex challenge that requires deep knowledge ... knowledge to improve therapeutic options and outcomes has been ... professor of biomedical engineering, since he joined the NJIT ... whose significance is underscored by substantial funding from sources ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 A new ... during the 2014 Society for Cardiovascular Angiography and Interventions ... released this week. The videos review the benefits of ... services for the cardiac catheterization laboratory from the perspective ... the first video, Jane Kiah, MS, RN, Director of ...
(Date:7/29/2014)... TUESDAY, July 29, 2014 (HealthDay News) -- Quitting smoking is ... review. Depression can make it more difficult to ... come with trying to quit cold turkey, scientists found. But ... people quit faster, they said. "The review should be ... Moullec, a postdoctoral researcher in the department of exercise science ...
(Date:7/29/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... J. Bowers, PhD, RN, FAAN, of the University of ... on Minority Issues in Gerontology Outstanding Mentorship Award. , ... who has exemplified outstanding commitment and dedication to mentoring ... award presentation will take place at GSA,s 67th Annual ...
(Date:7/29/2014)... drinkers are three times more likely to drink alcohol ... to other alcohol brands, providing new and compelling evidence ... drinking behavior. , This is the conclusion ... Marketing and Youth (CAMY) at the Johns Hopkins Bloomberg ... of Public Health that examined whether exposure to brand-specific ...
Breaking Medicine News(10 mins):Health News:Continuing the Quest for Better Stroke Therapies 2Health News:Continuing the Quest for Better Stroke Therapies 3Health News:Continuing the Quest for Better Stroke Therapies 4Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 3Health News: Extra Exercise Could Help Depressed Smokers Quit: Study 2Health News:Bowers to receive GSA's 2014 Minority Mentorship Award 2Health News:Brand-specific television alcohol ads predict brand consumption among underage youth 2
... 12, 2008 ... , WHO/ WHAT: "Iron Andy" Holder, an Ironman Arizona competitor who was ... this Sunday,s triathlon to encourage others who have chronic ... their condition and to live without limits., ...
... Up to Promote New Appliance Line,s European, Style and Ingenious Features ... ... YORK, April 3, 2008 Known and admired for her,multi-tasking talents as ... Ripa for the North America launch of its new,premium kitchen appliance line ...
... screening, recommended by the Centers for Disease Control, ... critical to preventing still births and serious birth ... study published in the April issue of the ... statistics, when used to determine screening rates, may ...
... gap between stated and unstated feelings about Clinton, ... people feel more "insecure" than they are typically willing,to ... Company. In,addition, the "confidence" voters express about the U.S. ... surface and therefore does not appear to be,very deep., ...
... April 3, 2008 /PRNewswire/ - The GLOBAL ... service for,business executives in pharmaceutical and life ... and other industries,launches a Virtual Tour of ... COUNCIL service by visiting, http://www3.best-in-class.com/gr148.htm or ...
... The International Neuroinformatics Coordinating Facility (INCF) announces further ... the Neuroscience Peer Review Consortium (NPRC) initiative. The ... have agreed to accept manuscript reviews from other ... research articles. Currently, 27 journals have joined the ...
Cached Medicine News:Health News:Ironman Competitor with Diabetes Encourages Others to Live Without Limits; Competes in Ironman Arizona in Tempe 2Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 2Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 3Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 4Health News:Prenatal syphilis screening rates: Are they being accurately reported? 2Health News:Voting for Clinton Evokes Deep-Seated Feelings of Insecurity 2Health News:Global Benchmarking Council Launches New Virtual Tour of Research & Networking Service 2Health News:Neuroscience Peer Review Consortium announces increased journal participation 2
High-quality eyecare from the preferred name in diagnostic instruments....
Our 2.5v Streak Retinoscope Sets feature instruments with bright light, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Medicine Products: